Reponex
Pre-clinicalReponex develops novel immunotherapies for cancer treatment.
Founded
2018
Focus
OncologyImmunology
About
Reponex develops novel immunotherapies for cancer treatment.
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedMay 15, 2022
Company Info
TypePrivate
Founded2018
LocationCopenhagen, Denmark
StagePre-clinical
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile